DNA-Mediated Magnetic-Dimer Assembly for Fault-Free Ultra-High-Field Magnetic Resonance Imaging of Tumors

• Published in: Nano letters Vol. 24; no. 22; pp. 6696 - 6705
• Main Authors: Liu, Xun, Liang, Zeyu, Du, Hui, Zhang, Bo, Wang, Qiyue, Xie, Shangzhi, Xiao, Lin, Chen, Ying, Wang, Yuqi, Li, Fangyuan, Ling, Daishun
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 26.05.2024
• Subjects: DNA-mediated assembly; magnetic resonance imaging; dual-mode contrast agent; fault-free
• ISSN: 1530-6984; 1530-6992
• DOI: 10.1021/acs.nanolett.4c01389

Ultra-high-field (UHF) magnetic resonance imaging (MRI) stands as a pivotal cornerstone in biomedical imaging, yet the challenge of false imaging persists, constraining its full potential. Despite the development of dual-mode contrast agents improving conventional MRI, their effectiveness in UHF remains suboptimal due to the high magnetic moment, resulting in diminished T1 relaxivity and excessively enhanced T2 relaxivity. Herein, we report a DNA-mediated magnetic-dimer assembly (DMA) of iron oxide nanoparticles that harnesses UHF-tailored nanomagnetism for fault-free UHF-MRI. DMA exhibits a dually enhanced longitudinal relaxivity of 4.42 mM–1·s–1 and transverse relaxivity of 26.23 mM–1·s–1 at 9 T, demonstrating a typical T1-T2 dual-mode UHF-MRI contrast agent. Importantly, DMA leverages T1-T2 dual-modality image fusion to achieve artifact-free breast cancer visualization, effectively filtering interference from hundred-micrometer-level false-positive signals with unprecedented precision. The UHF-tailored T1-T2 dual-mode DMA contrast agents hold promise for elevating the accuracy of MR imaging in disease diagnosis.